Well this long quiet period could only amount to one thing!!! Nothing New!!!!
Sure liked the idea of Clinical Trials but so far that is all it is (an idea) without any NR naming and confirming on paper movement forward. Which of course would require a relist. SEC meeting long past and no updates!!!